MX2024005220A - Endoxifeno para el tratamiento del cancer. - Google Patents

Endoxifeno para el tratamiento del cancer.

Info

Publication number
MX2024005220A
MX2024005220A MX2024005220A MX2024005220A MX2024005220A MX 2024005220 A MX2024005220 A MX 2024005220A MX 2024005220 A MX2024005220 A MX 2024005220A MX 2024005220 A MX2024005220 A MX 2024005220A MX 2024005220 A MX2024005220 A MX 2024005220A
Authority
MX
Mexico
Prior art keywords
cancers
cancer
endoxifen
compositions
treatment
Prior art date
Application number
MX2024005220A
Other languages
English (en)
Spanish (es)
Inventor
Steven C Quay
Carla Grandori
Katannya Kapeli
Original Assignee
Atossa Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atossa Therapeutics Inc filed Critical Atossa Therapeutics Inc
Publication of MX2024005220A publication Critical patent/MX2024005220A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2024005220A 2021-10-28 2022-10-27 Endoxifeno para el tratamiento del cancer. MX2024005220A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163272869P 2021-10-28 2021-10-28
PCT/US2022/048061 WO2023076496A1 (en) 2021-10-28 2022-10-27 Endoxifen for treatment of cancers

Publications (1)

Publication Number Publication Date
MX2024005220A true MX2024005220A (es) 2024-05-16

Family

ID=86158538

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024005220A MX2024005220A (es) 2021-10-28 2022-10-27 Endoxifeno para el tratamiento del cancer.

Country Status (10)

Country Link
US (1) US20250041245A1 (https=)
EP (1) EP4422608A4 (https=)
JP (1) JP2024541900A (https=)
KR (1) KR20240093500A (https=)
CN (1) CN118159259A (https=)
AU (1) AU2022378576A1 (https=)
CA (1) CA3232972A1 (https=)
IL (1) IL312037A (https=)
MX (1) MX2024005220A (https=)
WO (1) WO2023076496A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4304574A4 (en) * 2021-03-11 2024-11-20 Atossa Therapeutics, Inc. ENDOXIFEN FOR THE TREATMENT OF OVARIAN CANCER
CN117338780A (zh) * 2023-09-21 2024-01-05 中国人民解放军海军军医大学 帕罗西汀在制备抗肿瘤药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013033430A1 (en) * 2011-09-02 2013-03-07 Wake Forest School Of Medicine Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof
ES2769634T3 (es) * 2011-11-04 2020-06-26 Szewczuk Myron R Uso de inhibidores de la sialidasa NEU1 en el tratamiento del cáncer
DE102015222031A1 (de) * 2015-11-10 2017-05-11 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Synthese von (Z)-Endoxifenhydrochlorid
WO2017127442A1 (en) * 2016-01-18 2017-07-27 The Regents Of The University Of California Methods for treating cancer with rorgamma inhibitors
JP7662204B2 (ja) * 2019-07-03 2025-04-15 アトッサ・セラピューティクス・インコーポレイテッド エンドキシフェンの徐放性組成物
JP7792335B2 (ja) * 2019-12-12 2025-12-25 センティ バイオサイエンシズ インコーポレイテッド 細胞の調節されたアーマリングのための方法及び組成物
EP4304574A4 (en) * 2021-03-11 2024-11-20 Atossa Therapeutics, Inc. ENDOXIFEN FOR THE TREATMENT OF OVARIAN CANCER
AU2023260712A1 (en) * 2022-04-26 2024-11-14 Atossa Therapeutics, Inc. High dose endoxifen formulations and methods of use

Also Published As

Publication number Publication date
EP4422608A4 (en) 2025-09-24
WO2023076496A1 (en) 2023-05-04
IL312037A (en) 2024-06-01
JP2024541900A (ja) 2024-11-13
CA3232972A1 (en) 2023-05-04
AU2022378576A1 (en) 2024-03-28
CN118159259A (zh) 2024-06-07
EP4422608A1 (en) 2024-09-04
US20250041245A1 (en) 2025-02-06
KR20240093500A (ko) 2024-06-24

Similar Documents

Publication Publication Date Title
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
NZ784224A (en) Parp1 inhibitors
PH12020550901A1 (en) Macrocyclic compounds for treating disease
EA201890009A1 (ru) Ингибиторы ezh2 для лечения лимфомы
MX390535B (es) Compuestos de amino-triazolopiridina y su uso en el trataniento del cancer.
PH12020551427A1 (en) Epinephrine spray formulations
MX391720B (es) Terapia combinada para tratar cáncer.
JO3735B1 (ar) مركبات ألكين بها استبدال رباعي واستخداماتها
MX376193B (es) Compuestos para tratar el cancer cerebral.
MX420412B (es) Plinabulina, composiciones que la comprenden y sus usos en el tratamiento de cáncer asociado con mutación del egfr.
MX2019003722A (es) Composiciones inmunogénicas de tert y métodos de tratamiento que las utilizan.
MX2016015378A (es) Uso de eribulina en el tratamiento de cancer.
EA202091112A1 (ru) Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение
BR112018011177A2 (pt) conjugados de citarabina para terapia de câncer
CO2020013968A2 (es) Derivados de pladeniolida como agentes dirigidos a empalmosoma para tratar el cáncer
ZA202304965B (en) Combination therapy for treating cancer
JOP20200242A1 (ar) مركبات البلاديينوليد واستخداماتها
MX2018010223A (es) Terapia combinada para tratamiento de cancer de ovario.
MX2024005220A (es) Endoxifeno para el tratamiento del cancer.
MX2020001727A (es) Terapia de combinacion.
EA201792294A1 (ru) Комбинированное лечение (варианты) с применением серибантумаба
MX2021013901A (es) Composiciones y métodos para el tratamiento del cáncer.
MX382357B (es) Métodos y composiciones para tratar infecciones fúngicas cutáneas.
JOP20200124A1 (ar) طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
EA201892631A1 (ru) Дигидротестостерон и производные и промоторы дигидротестостерона в лечении рака